Literature DB >> 20656163

Effect of intracameral epinephrine use on macular thickness after uneventful phacoemulsification.

Ercument Bozkurt1, Ahmet Taylan Yazici, Gökhan Pekel, Sinan Albayrak, Mehmet Cakir, Evre Pekel, Omer Faruk Yilmaz.   

Abstract

PURPOSE: To evaluate changes in central macular thickness using optical coherence tomography after uneventful cataract surgery combined with intracameral epinephrine use.
SETTING: Beyoğlu Eye Training and Research Hospital, Istanbul, Turkey.
METHODS: This prospective case series comprised eyes of consecutive patients who had uneventful phacoemulsification and in-the-bag intraocular lens (IOL) implantation between August 2005 and January 2006. The eyes were randomly assigned to 1 of 2 groups. In 1 group, 0.2 mL epinephrine (1:5000 solution) was injected just after the clear corneal incision was created. The other group (control) did not receive epinephrine. Optical coherence tomography was performed in all eyes preoperatively as well as postoperatively at 1 day, 1 week, and 1, 3, and 6 months.
RESULTS: The epinephrine group comprised 73 eyes (73 patients) and the control group, 76 eyes (86 patients). In both groups, the increase in retinal thickness from preoperatively to 1, 3, and 6 months postoperatively was statistically significant (P<.05); the difference was not statistically significant at 1 day or 1 week in either group (P>.05). There were no statistically significant differences between the 2 groups in mean retinal thickness throughout the follow-up (P>.05). Clinically significant macular edema occurred in 3 eyes in the epinephrine group and 3 eyes in the control group.
CONCLUSION: Although epinephrine is a well-known risk factor for central macular edema, intracameral injection of 0.2 mL epinephrine (1:5000) did not increase the risk for central macular edema in eyes with no risk factors that had uneventful phacoemulsification with IOL implantation. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned. Copyright 2010 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656163     DOI: 10.1016/j.jcrs.2010.02.020

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  7 in total

1.  The effect of intracameral anesthesia on macular thickness and ganglion cell-inner plexiform layer thickness after uneventful phacoemulsification surgery: prospective and randomized controlled trial.

Authors:  Esin Sogutlu Sari; Sitki Samet Ermis; Alper Yazici; Arif Koytak; Gözde Sahin; Adil Kilic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-05       Impact factor: 3.117

Review 2.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

3.  Phacoemulsification without preoperative mydriasis in patients with age-related cataract associated with type 2 diabetes.

Authors:  Rajesh Subhash Joshi
Journal:  Clin Ophthalmol       Date:  2016-12-05

4.  Transient complete visual loss and subsequent cystoid macular edema after intracameral lidocaine injection following uneventful cataract surgery.

Authors:  Mehrdad Mohammadpour; Hamid Riazi-Esfahani
Journal:  J Curr Ophthalmol       Date:  2017-09-20

5.  Assessment for Macular Thickness after Uncomplicated Phacoemulsification Using Optical Coherence Tomography.

Authors:  Byung-Jin Kim; Ye Jin Ahn; Hye-Young Oh; Soon Il Choi; Young-Sik Yoo; Woong-Joo Whang; Yong-Soo Byun; Mee-Yon Lee; Choun-Ki Joo
Journal:  Korean J Ophthalmol       Date:  2022-05-06

6.  Phacoemulsification without preoperative topical mydriatics: induction and sustainability of mydriasis with intracameral mydriatic solution.

Authors:  Sanjiv K Gupta; Ajai Kumar; Swati Agarwal; Siddarth Agarwal
Journal:  Indian J Ophthalmol       Date:  2014-03       Impact factor: 1.848

7.  Efficacy and safety of intraoperative intracameral mydriasis in manual small incision cataract surgery - A randomized controlled trial.

Authors:  K Ajay; Srinivasan Saranya; Divya Dabir Sundaresh; H R Hithashree; B C Hemalatha; Malavika Krishnaswamy; Sathyendranath B Shetty
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.